Harrow Eye, LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$3.0Mgeneral payments (2019-2025)
$1,167research payments (2019-2025)
10,638clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Vevye $1.7M associated (2023-2025)
- Iheezo $838K associated (2023-2025)
- Triesence $614K associated (2023-2025)
- Flarex $16K associated (2023-2025)
- Natacyn $15K associated (2023-2025)
- Tobradex St $15K associated (2023-2025)
- Verkazia $14K associated (2023-2025)
- Ilevro $3,278 associated (2023-2025)
- Vigamox $750 associated (2023-2025)
- Zerviate $78.66 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Seenu Hariprasad | Chicago, IL | Ophthalmology | $203,363.59 |
| Richard Adler | Baltimore, MD | Ophthalmology | $197,009.41 |
| Paul Karpecki | Lexington, KY | Optometrist | $161,575.64 |
| Uday Devgan | Los Angeles, CA | Ophthalmology | $150,000.00 |
| Raj Patel | Hendersonville, NC | Ophthalmology | $137,218.65 |
| Martin Makary | Baltimore, MD | Surgery | $135,456.66 |
| Amy Miller | Dayton, OH | Ophthalmology | $77,783.36 |
| Michael Singer | San Antonio, TX | Ophthalmology | $68,038.63 |
| Ian Gaddie | Louisville, KY | Corneal and Contact Management | $49,160.14 |
| Ranjan Malhotra | Saint Louis, MO | Ophthalmology | $46,677.12 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.